| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,369 |
2,190 |
$342K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
491 |
419 |
$265K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,275 |
2,084 |
$225K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
346 |
331 |
$117K |
| G0378 |
Hospital observation service, per hour |
761 |
648 |
$105K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
795 |
702 |
$95K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
193 |
191 |
$52K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
529 |
508 |
$45K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
6,875 |
4,866 |
$44K |
| 80053 |
Comprehensive metabolic panel |
6,305 |
5,207 |
$37K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
113 |
107 |
$37K |
| 71046 |
Radiologic examination, chest; 2 views |
631 |
583 |
$32K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,590 |
1,250 |
$30K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,421 |
5,172 |
$28K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,251 |
2,157 |
$27K |
| 87631 |
|
164 |
160 |
$22K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
60 |
58 |
$22K |
| 70450 |
Computed tomography, head or brain; without contrast material |
90 |
84 |
$21K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,223 |
1,008 |
$20K |
| 36415 |
Collection of venous blood by venipuncture |
8,134 |
6,391 |
$15K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
19 |
17 |
$15K |
| 71045 |
Radiologic examination, chest; single view |
854 |
762 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
240 |
231 |
$9K |
| 80061 |
Lipid panel |
1,301 |
1,235 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
927 |
778 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,038 |
983 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
411 |
225 |
$7K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
326 |
312 |
$7K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
52 |
29 |
$6K |
| 86140 |
|
1,538 |
1,326 |
$6K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
15 |
14 |
$5K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
363 |
331 |
$5K |
| 85027 |
|
1,281 |
1,119 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
31 |
28 |
$5K |
| 83880 |
|
424 |
327 |
$4K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
12 |
12 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
871 |
665 |
$4K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
196 |
192 |
$4K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
436 |
364 |
$4K |
| 93296 |
|
259 |
249 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
189 |
183 |
$3K |
| 0099U |
|
14 |
14 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
602 |
552 |
$3K |
| 84439 |
|
304 |
292 |
$3K |
| 83735 |
|
1,244 |
904 |
$3K |
| 73630 |
|
43 |
39 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
73 |
71 |
$2K |
| 81003 |
|
978 |
900 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
79 |
77 |
$2K |
| 87430 |
|
87 |
85 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
49 |
49 |
$2K |
| 85610 |
|
1,267 |
1,056 |
$2K |
| 81025 |
|
534 |
491 |
$2K |
| 81001 |
|
960 |
864 |
$2K |
| 85007 |
|
741 |
616 |
$2K |
| 82607 |
|
163 |
152 |
$2K |
| 84484 |
|
875 |
588 |
$1K |
| 85652 |
|
517 |
467 |
$1K |
| 82550 |
|
1,009 |
694 |
$1K |
| 83690 |
|
406 |
364 |
$1K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
25 |
24 |
$968.31 |
| 74019 |
|
14 |
14 |
$932.44 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
45 |
44 |
$694.26 |
| 84100 |
|
681 |
542 |
$639.87 |
| 85730 |
|
592 |
502 |
$615.41 |
| 97161 |
|
55 |
51 |
$610.76 |
| G0008 |
Administration of influenza virus vaccine |
243 |
231 |
$586.83 |
| 81015 |
|
357 |
332 |
$582.70 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
454 |
261 |
$546.00 |
| A9270 |
Non-covered item or service |
979 |
94 |
$514.98 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
483 |
395 |
$511.45 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
498 |
356 |
$441.63 |
| 83540 |
|
102 |
97 |
$413.48 |
| 73560 |
|
12 |
12 |
$413.24 |
| 82948 |
|
577 |
207 |
$410.28 |
| 83874 |
|
678 |
473 |
$404.54 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
51 |
12 |
$379.98 |
| 90686 |
|
121 |
116 |
$371.09 |
| 82553 |
|
714 |
497 |
$365.73 |
| 87420 |
|
31 |
30 |
$346.34 |
| 88342 |
|
30 |
27 |
$316.92 |
| 87186 |
|
53 |
50 |
$239.02 |
| 87081 |
|
32 |
32 |
$233.10 |
| 82150 |
|
244 |
216 |
$232.76 |
| 87077 |
|
84 |
80 |
$224.96 |
| 84145 |
|
134 |
108 |
$216.56 |
| 87807 |
|
14 |
14 |
$207.20 |
| 93299 |
|
12 |
12 |
$170.31 |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
12 |
12 |
$144.39 |
| 82728 |
|
24 |
24 |
$142.35 |
| J2704 |
Injection, propofol, 10 mg |
344 |
295 |
$113.46 |
| 85379 |
|
134 |
122 |
$103.43 |
| 84466 |
|
13 |
13 |
$93.56 |
| 80306 |
|
55 |
51 |
$82.24 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
277 |
226 |
$72.15 |
| 90662 |
|
64 |
60 |
$47.32 |
| 84703 |
|
12 |
12 |
$29.89 |
| 87040 |
|
85 |
48 |
$23.19 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
162 |
113 |
$21.33 |
| 83550 |
|
40 |
39 |
$9.61 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
870 |
602 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
234 |
203 |
$0.00 |
| 96376 |
|
64 |
59 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
167 |
144 |
$0.00 |
| 94760 |
|
75 |
65 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
33 |
28 |
$0.00 |
| 83605 |
|
108 |
82 |
$0.00 |
| 90688 |
|
19 |
19 |
$0.00 |